Ovarian Cancer Research Symposium
The Rivkin Center and the American Association for Cancer Research are proud to present the 15th Biennial Ovarian Cancer Research Symposium on September 20-21, 2024 at the Seattle Airport Marriott in Seattle, WA.
SYMPOSIUM INFO
Since 1996, this Symposium has brought together clinicians and researchers from across many disciplines and institutions worldwide to share ideas and advance the field of ovarian cancer research. We seek to enhance understanding and knowledge, discuss recent innovations in research and treatment, and address pressing concerns of leaders in the clinical and research community.
Ovarian cancer is the leading cause of gynecological cancer-related deaths. Because its symptoms can be easily dismissed, 80% of ovarian cancers are diagnosed in late stages when prognosis is poor. The 5-year survival of epithelial ovarian cancer is 93% if diagnosed in the early, localized state, and plummets to 31% if found in late stages. Understanding the risk factors and improved early detection methods are key to detecting ovarian cancer in its early, more survivable stages. Ovarian cancer’s high recurrence rate also makes deep knowledge of chemoresistance, recurrence, and tumor biology essential.
The Biennial Ovarian Cancer Research Symposium addresses these major needs in ovarian cancer research and treatment with sessions covering novel therapeutics, immune-oncology, tumor microenvironment, early detection, prevention, DNA repair, and rare tumors. We will also hold discussions about health and healthcare disparities and the role of patient advocacy in research.
Continuing Medical Education Activity – AMA PRA Category 1 CreditsTM will be available. Return later for details.
SESSION TOPICS
The session topics were developed by our co-chairs. Each session will feature invited lectures by experts in the field, as well as proffered talks from selected abstracts. Abstracts not selected for oral talks may be invited to present a poster.
- Biology of Ovarian Cancer
- Prevention, Early Detection, & Interception
- Emerging Therapeutics
- Novel Immunotherapies
- Healthcare Disparities
- Patient Advocacy
LOCATION & TRAVEL
There are free shuttles between the SeaTac Airport (SEA) and the venue, the Seattle Airport Marriott, every 15 minutes, 24 hours a day. See the Lodging tab for more information and a discounted room rate.
IMPORTANT DATES
- March 28, 2024: Abstract Submission Opens
- May 1, 2024: Online Registration Opens
- June 18, 2024: Abstract Submission Closes
- July 22, 2024: Abstract Notifications
- August 5, 2024: Early Registration Closes – rate increase
CONTACT
For questions, please contact Jackie Lang at jackie.lang@rivkin.org or (206)490-0847 x104
Recent Symposia
To join the Rivkin Center Science email list and receive information for researchers and clinicians about ovarian cancer research grants and symposia, email Jackie Lang, PhD.
The 2024 Symposium is fully live; it will not have virtual or recorded components. Please register to join us in Seattle. To submit an abstract, please visit the Abstracts tab. The abstract submission deadline is June 18, 2024.
This is a rough approximation of the Program schedule. Exact timings may change as the program is further developed. We will add more details as they become available.
Friday, September 20th, 2024 8:00 am – 9:00 pm
Opening Keynote
Patient Advocacy Panel
Session 1: Healthcare Disparities
Lunch and Breakout Discussions
Session 2: Biology of Ovarian Cancer
Session 3: Prevention, Early Detection, & Interception
Poster Session and Reception
Saturday, September 21st, 2024 8:00 am – 5:00 pm
Session 4: Emerging Therapeutics
Poster Session
Lunch
Session 5: Novel Immunotherapies
Closing Keynote
REGISTRATION
Early registration is open May 1 – August 5, 2024.
ACCOMMODATIONS
We have arranged for a special group rate at the Seattle Airport Marriott, where the symposium is being held.
Seattle Airport Marriott
3201 S 176th St
Seattle, WA 98188
1-206-241-2000
Our Group Rate is $179 for a Standard room (1 King or 2 Queens). Rates are non-commissionable exclusive of state and local taxes and fees. Cancellation policies apply. The Rivkin Center will not reimburse penalties for late cancellations.
Please note the group rate is available during the symposium and for several nights pre- and post-event if the hotel has availability and on a first come first serve basis. You can book any number of nights to get the group rate.
Online Reservation Instructions
If you are booking on or before August 29, 2024 click on our group link and follow the instructions.
Phone Reservation Instructions
If you are booking on or after August 30, 2024, call the Marriott directly (1-206-241-2000). Tell them you are with the Rivkin Group and they will assist you with making your reservation using our Group Rate.
GETTING THERE
There are free shuttles between the SeaTac Airport (SEA) and the Seattle Airport Marriott, every 15 minutes, 24 hours a day.
PARKING
Parking is available at the Marriott for $16 per day for daytime parking. Overnight parking is $30 per night.
We are accepting research and clinical abstracts in all fields of ovarian cancer research. Select abstracts will be invited to present 10-minute oral presentations. Other abstracts may be invited to give poster presentations. All abstract presenters must register for the Symposium.
SUBMIT AN ABSTRACT
Individuals interested in submitting an abstract for poster or oral presentation must do so here. Create a profile, complete and submit the Abstract Submission Form, then you will be able to enter in co-authors on the abstract. The submitting author does not need to be the presenting author, unless the author is also applying for a Rivkin Center Travel Scholarship (see the Travel Awards tab for details). An individual may submit up to two abstracts.
The abstract submission deadline is Tuesday, June 18, 2024 at 5 pm Pacific Time.
ABSTRACT CATEGORIES
- Biology of Ovarian Cancer
- Prevention, Early Detection, & Interception
- Emerging Therapeutics
- Novel Immunotherapies
- Health & Healthcare Disparities
- Survivorship
- Patient Advocacy
- Other
NOTIFICATION OF ABSTRACT STATUS
Presenting authors will be notified of acceptance or rejection for poster or oral presentation by email approximately July 22, 2024.
PRESENTATION AND PUBLICATION
If selected for a proffered talk, the abstract title and presenter name and institution will be posted on the Symposium website once the presenting author accepts the offer to present.
Presenting authors will be emailed instructions with the date, time, and format for their presentations.
REGISTRATION
All presenting authors must register for the Symposium. If an abstract is not selected for presentation, the presenting author may request a full refund of the registration fee by contacting the AACR Meetings Department at meetings@aacr.org.
ABSTRACT WITHDRAWAL
Once an abstract has been submitted, the submitting and/or presenting author may withdrawal the abstract at any time by logging on to your profile on the abstract submission website. Navigate to ‘Submission Home’ and select ‘Withdraw Submission’ below the abstract you want to withdraw.
Rivkin Center Travel Scholarships
The Rivkin Center is offering $500 Travel Scholarships to support graduate students and postdocs who would otherwise be unable to attend the Symposium. To be eligible for a Travel Scholarship, you must be the submitter and presenting author of an abstract accepted for presentation (poster or proffered talk). Special consideration will be given to those from underrepresented or underserved backgrounds and regions.
To apply for a Travel Scholarship, you must submit an abstract (see the Abstracts tab for details). Included in the Abstract Submission Form is an optional question that will serve as your Travel Scholarship application.
You will be asked to submit a personal statement including (225 words max):
- A description of where you are in your scientific career (include your institution and mentor)
- Your research interests
- Why you would like to be considered for a Travel Scholarship
- How attending and presenting at the Symposium will impact your career and research
The deadline is the same as the abstract submission deadline: Tuesday, June 18, 2024 at 5 pm Pacific Time.
Ovarian Cancer Research Symposium Chairs
The purpose of the Chairs is to develop the scope and goals of the 15th Biennial Ovarian Cancer Research Symposium. The members’ collective expertise informed the selection of invited speakers, topics of the Sessions, and all elements of the programming. The Symposium seeks to enhance the understanding and knowledge of ovarian cancer, especially among junior and young investigators, discuss the most recent innovations in the field of ovarian cancer research, and address the pressing concerns among the leaders of the clinical and research community.
Co-chairs
Joyce Liu, MD, MPH
Dana-Farber Cancer Institute
Nita Maihle, PhD
University of Mississippi
Brad Nelson, PhD
BC Cancer Research
Dmitriy Zamarin, MD, PhD
Mount Sinai
Planning Committee
Jackie Lang, PhD
Rivkin Center
Roslin Thoppil, PhD
American Association for Cancer Research
For more information about sponsoring the 2024 biennial Ovarian Cancer Research Symposium, please review our Sponsor Benefits Package or contact Kim Isaac, Interim Director of Development, at kim.isaac@rivkin.org.